Kathy Manguiat

1.5k citations
14 papers · 573 indexed · h-index 9
Topics
SARS-CoV-2 and COVID-19 Research (8 papers)COVID-19 Clinical Research Studies (5 papers)SARS-CoV-2 detection and testing (4 papers)

In The Last Decade

Kathy Manguiat

14 papers receiving 568 citations

Peers

Kathy Manguiat
Comparison fields: 5 of 79
  • Infectious Diseases 281
  • Molecular Biology 224
  • Cancer Research 99
  • Neurology 78
  • Immunology 62
Replace Young‐Chan Kwon with:
Young‐Chan Kwon South Korea
Xiaoyuan Lin China
Nabab Khan United States
Eugene L. Asahchop Canada
Martha-Eugenia Ruiz‐Tachiquín Mexico
Yunru Yang China
Olga González‐López United States
Marsha S. Russell Canada
Liangwei Duan China
Maren de Vries United States
Kathy Manguiat relative to Young‐Chan Kwon South Korea Young‐Chan Kwon's profile →
Citations per field
00.5×1.5×1.9×
Young‐Chan Kwon · 1×
Citations per year

Countries citing papers authored by Kathy Manguiat

Since Specialization
Citations

This map shows the geographic impact of Kathy Manguiat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Manguiat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Manguiat more than expected).

Fields of papers citing papers by Kathy Manguiat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Manguiat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Manguiat. The network helps show where Kathy Manguiat may publish in the future.

Co-authorship network of co-authors of Kathy Manguiat

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Manguiat. A scholar is included among the top collaborators of Kathy Manguiat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Manguiat. Kathy Manguiat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 3
2 6
3 67
4 3
5 27
6 2
7 4
8 10
9 63
10 145
11 21
12 131
13 81
14 10

About Kathy Manguiat

Kathy Manguiat is a scholar working on Infectious Diseases, Parasitology and Developmental Neuroscience, having authored 14 papers that have together received 573 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (5 papers) and SARS-CoV-2 detection and testing (4 papers). The work is most often cited by research in Infectious Diseases (281 citations), Neurology (78 citations) and Cancer Research (99 citations). Kathy Manguiat has collaborated with scholars based in Canada, Colombia and United States. Frequent co-authors include Heidi Wood, Michael Drebot, Emelissa J. Mendoza, Stephanie A. Booth, Sarah J. Medina, Reuben Saba, Catherine C. Robertson, Alyssia Robinson, Kathy L. Frost and Anna Majer. Their work appears in journals such as Nature Immunology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026